General Radar develops high resolution 3d radar for autonomous systems. The company was founded in 2016 and is based in Mountain View, California.
FreeWire Technologies, Inc. is a manufacturer of mobile electric vehicle (EV) chargers based in San Leandro, California. Established in 2014, the company specializes in smart battery systems that provide mobile and distributed power solutions. Its product line includes the Mobi Charger v0, capable of charging at speeds of up to 5kW, the Mobi Charger v1, which offers charging as a service with attendant support, and the Mobi Charger v2, a semi-autonomous unit that provides dual level 2 and single level 3 charging options. FreeWire's systems deliver clean and quiet power on-site, effectively replacing or supplementing diesel generators for various remote power applications. By offering flexible and easily deployable charging solutions, FreeWire enables its customers to electrify operations previously reliant on fossil fuels while avoiding the complexity and costs associated with traditional infrastructure upgrades. The company is supported by venture capital and partnerships with global corporations.
Cornami, Inc. is a high-performance computing company based in Campbell, California, with additional offices in Sacramento and Boston. Established in 2011, the company specializes in innovative technologies that enhance software performance, power efficiency, latency, and computational footprints. Cornami has developed patented multi-core technology that optimizes the use of heterogeneous cores in a concurrent and parallel manner. This technology enables scalability from thousands of cores on a single chip to millions across a system, facilitating real-time computing while minimizing costs and power consumption. The company aims to significantly improve compute performance in various markets, particularly focusing on Big Data. Additionally, Cornami's technology supports real-time fully homomorphic encryption, allowing developers and enterprises to achieve high performance on any device, thereby enhancing return on investment and operational efficiency.
Cornami, Inc. is a high-performance computing company based in Campbell, California, with additional offices in Sacramento and Boston. Established in 2011, the company specializes in innovative technologies that enhance software performance, power efficiency, latency, and computational footprints. Cornami has developed patented multi-core technology that optimizes the use of heterogeneous cores in a concurrent and parallel manner. This technology enables scalability from thousands of cores on a single chip to millions across a system, facilitating real-time computing while minimizing costs and power consumption. The company aims to significantly improve compute performance in various markets, particularly focusing on Big Data. Additionally, Cornami's technology supports real-time fully homomorphic encryption, allowing developers and enterprises to achieve high performance on any device, thereby enhancing return on investment and operational efficiency.
Osaro, Inc. develops industrial-grade artificial intelligence (AI) software to automate the manual picking and assembly tasks in distribution centers and manufacturing facilities. It offers automation solutions for computer and robotic systems driven by advanced machine learning software. The company also provides machine learning products that automatically processes large amounts of unstructured data and learns complex control tasks. Osaro, Inc. was incorporated in 2015 and is based in San Francisco, California.
ZeroEyes, Inc. is an artificial intelligence security company based in Philadelphia, Pennsylvania, founded in 2018. It specializes in a platform designed to detect weapons and prevent casualties, primarily through the integration of existing camera systems. The technology relies on computer vision to identify firearms and provides immediate alerts to authorities, enhancing situational awareness and reducing response times for first responders. ZeroEyes' solutions cater to various sectors, including education, corporate and retail environments, healthcare facilities, and live events. The platform can track multiple suspects in real time as they move through surveillance areas, effectively acting as an early warning system for firearm-related threats.
RED 6 INC. specializes in outdoor augmented reality solutions specifically designed for air combat training. The company has developed the Airborne Tactical Augmented Reality System (ATARS), which integrates virtual and constructive assets into real-world environments. This innovative system enables pilots and ground operators to identify and engage synthetic threats in real-time, even in high-speed outdoor conditions. Founded in 2017, RED 6 is headquartered in Santa Monica, California, and aims to enhance training effectiveness by allowing real pilots in actual aircraft to visually maneuver against computer-generated adversaries.
Advocado is the first real-time cross-media optimization & audience platform that makes advertising perform better by using signals in the physical world (like TV Ads or in-program content) to trigger real-time actions across search, social and shopping platforms and building organic digital audiences based on advertiser affinity; all the while, collecting the data to prove value created. Ultimately, we help CMO’s and marketing leaders deliver better results while breaking down organizational silos and respecting consumer privacy.
Valted Seq is a discovery stage biopharmaceutical company based in Gaithersburg, Maryland, focused on developing therapeutics for neurodegenerative diseases such as Alzheimer's and Parkinson's. The company leverages big data to identify novel biomarkers and neurodegenerative pathways, which are crucial for the advancement of new therapeutics and diagnostics, including companion diagnostics. Valted Seq has established the world’s largest repository of single-cell sequencing data derived from high-quality, clinically characterized brain tissues of patients suffering from these conditions. This extensive database supports the development of precision therapeutics, ensuring patients can access innovative treatments tailored to their specific needs.
Maidbot is on a mission to bridge the gap between robots and humans - starting with Rosie - the world's very first housekeeping robot for hotels and commercial buildings. Like a self-driving car, Rosie navigates intelligently through the space while cleaning floors and collecting invaluable operational and environmental data. Maidbot's automated systems deliver unprecedented value to hotel operators, room attendants, and hotel guests. There are three major issues Maidbot is tackling: *Housekeeping is the highest variable cost regardless of the hotel. *Room attendants have the highest injury rates in the service sector. *Current commercial cleaning practices are inconsistent and hard to objectively manage. By using Maidbot's systems, hotel and commercial cleaning operators will see an increase in profitability; healthier and happier staff; and higher guest satisfaction. In addition, room attendants will be able to focus on less strenuous tasks - ultimately reducing injury rates. Finally, guests will have a more enjoyable experience through consistent cleanliness and more flexible check-in and check-out times. Given the size and scale of the hospitality market, a lack of innovation in the field, and the potential to improve the health and safety of room attendants; Maidbot transforms the industry by leveraging the power of robotics. By solving the two biggest issues in housekeeping – time and injuries – Maidbot revolutionizes commercial cleaning - one bot at a time.
Finch Therapeutics is a mission-driven microbiome engineering company, is developing novel microbial therapies to serve patients with serious and unmet medical needs.
The company uses machine learning algorithms to reverse engineer successful fecal transplantations and other clinical datasets, identifying the microbes that drive responses in patients. This human-centric discovery model leverages clinical data to focus on in-vitro and in-vivo efforts on cocktails of microbes that have already demonstrated safety and efficacy in humans. This enables early retirement of translational risk and avoids the challenges of extrapolating host-specific effects from animal models.
Finch Therapeutics was founded in 2017 and is headquartered in Somerville, Massachusetts.
Luminar Technologies, Inc. is producing advanced sensor technologies for the autonomous vehicle industry. It built its LiDAR systems from scratch. That means the company engineered its own: lasers, receivers, chips, packaging and more, rather than incorporating off-the-shelf components. The company’s LiDARs give cars the ability to see obstacles ahead in much greater detail, and at much greater distances than any other systems on the market today. The LiDARs also work in inclement weather, through fog and dust.
Palantir Technologies develops data fusion platforms for a variety of users, including public institutions, commercial enterprises, and non-profit organizations globally. The company offers two main products: Palantir Gotham, which focuses on integrating, managing, and analyzing enterprise data, and Palantir Metropolis, designed for the integration and analysis of quantitative data. Their software applications facilitate collaboration among analysts across government organizations, enabling them to visualize and analyze large volumes of information. Palantir's solutions address diverse challenges in areas such as anti-fraud, cyber security, defense, healthcare, and legal intelligence. Founded in 2003 in Denver, Colorado, and now based in Palo Alto, California, Palantir has established strategic partnerships, including one with United Airlines.
D&D Pharmatech Co., Ltd. is a clinical-stage biotech company based in Seongnam, South Korea, established in 2014. The company focuses on developing innovative medicines across various therapeutic areas, including neurodegenerative, fibrotic, and metabolic diseases. It operates through disease-specific subsidiary companies that are guided by leading medical research faculty, facilitating the translation of advanced research into viable therapeutic products. D&D Pharmatech's expertise encompasses drug research and development, manufacturing quality control, and clinical development. Additionally, the company is involved in the development of positron emission tomography (PET) imaging biomarkers and single-cell sequencing technologies related to degenerative brain diseases. By leveraging advanced drug delivery technologies, such as PEGylation, D&D Pharmatech aims to enhance the effectiveness and outcomes of its therapeutic offerings.
Touch-Writer has created natural input technology that enables users of mobile devices to 'gesture' input including text, cursor movements, manipulate highlight areas and cut, copy and paste. We endeavor to improve the clumsy input experience offered by touch-keyboards, as well as the awkward features provided to do simple things such as move cursors and manipulate text. Touch-Writer uses originally derived gesture recognition technology which is the first of it's kind. We developed the technology during a long R&D period in Frankfurt, and are now based in Toronto. Touch-Writer is an Intellectual Property company - we license solutions to OEM's and 3rd party providers, we do not have a consumer solution product.